Search

Your search keyword '"Sando SB"' showing total 81 results

Search Constraints

Start Over You searched for: Author "Sando SB" Remove constraint Author: "Sando SB"
81 results on '"Sando SB"'

Search Results

1. Beyond the Global Brain Differences: Intraindividual Variability Differences in 1q21.1 Distal and 15q11.2 BP1-BP2 Deletion Carriers

2. 1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans

3. Identification of symbol digit modality test score extremes in Huntington's disease

4. GBA and APOE epsilon 4 associate with sporadic dementia with Lewy bodies in European genome wide association study (vol 9, 7013, 2019)

5. The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients

7. Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY

8. Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease

9. β-Defensin Genomic Copy Number Does Not Influence the Age of Onset in Huntington's Disease

10. Discrepancies in reporting the CAG repeat lengths for Huntington's disease

11. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

12. Replication of BIN1 association with Alzheimer's disease and evaluation of genetic interactions.

13. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.

14. Common Variants at Abca7, Ms4A6A/Ms4A4E, Epha1, Cd33 and Cd2Ap Are Associated with Alzheimer'S Disease

15. Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia.

16. A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors.

17. Beyond the Global Brain Differences: Intraindividual Variability Differences in 1q21.1 Distal and 15q11.2 BP1-BP2 Deletion Carriers.

18. Regression-based cognitive change norms applied in biochemically defined predementia Alzheimer's disease.

19. Association of Klotho Protein Levels and KL-VS Heterozygosity With Alzheimer Disease and Amyloid and Tau Burden.

20. Safety and efficacy of plasma transfusion from exercise-trained donors in patients with early Alzheimer's disease: protocol for the ExPlas study.

21. Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease.

22. Author Correction: A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease.

23. New insights into the genetic etiology of Alzheimer's disease and related dementias.

24. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.

25. Can exercise training teach us how to treat Alzheimer's disease?

26. Using Polygenic Hazard Scores to Predict Age at Onset of Alzheimer's Disease in Nordic Populations.

27. Author Correction: A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease.

28. CSF neurofilament light may predict progression from amnestic mild cognitive impairment to Alzheimer's disease dementia.

29. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease.

30. 1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans.

31. Time to Diagnosis in Young Onset Alzheimer's Disease: A Population-Based Study from Central Norway.

32. C9orf72 , age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts.

33. Demographically adjusted trail making test norms in a Scandinavian sample from 41 to 84 years.

34. Cerebrospinal fluid neuronal pentraxin receptor as a biomarker of long-term progression of Alzheimer's disease: a 24-month follow-up study.

35. Factors influencing employment after minor stroke and NSTEMI.

36. Association of Copy Number Variation of the 15q11.2 BP1-BP2 Region With Cortical and Subcortical Morphology and Cognition.

37. Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia.

38. Author Correction: Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.

39. Correction: Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia.

40. The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up.

41. Incidence of Young Onset Dementia in Central Norway: A Population-Based Study.

42. Author Correction: GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study.

43. The development of cognitive and emotional impairment after a minor stroke: A longitudinal study.

44. GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study.

45. Cognitive and Emotional Impairment after Minor Stroke and Non-ST-Elevation Myocardial Infarction (NSTEMI): A Prevalence Study.

46. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.

47. Plasma Apolipoprotein E Monomer and Dimer Profile and Relevance to Alzheimer's Disease.

48. The Prevalence and Subtypes of Young Onset Dementia in Central Norway: A Population-Based Study.

49. Meta-analysis of Alzheimer's disease on 9,751 samples from Norway and IGAP study identifies four risk loci.

50. The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease.

Catalog

Books, media, physical & digital resources